Archives of Plastic Surgery

Korean Society of Plastic and Reconstructive Surgeons (대한성형외과학회)
권호 표지
DOI QR코드

DOI QR Code

Dupuytren's Disease: A Novel Minimally Invasive Pull-Through Technique

  • Michele Maruccia (Division of Plastic and Reconstructive Surgery, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro) ;
  • Pasquale Tedeschi (Division of Plastic and Reconstructive Surgery, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro) ;
  • Francesco Sisto (Division of Plastic and Reconstructive Surgery, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro) ;
  • Ilaria Converti (Division of Plastic and Reconstructive Surgery, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro) ;
  • Giuseppe Giudice (Division of Plastic and Reconstructive Surgery, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro) ;
  • Rossella Elia (Division of Plastic and Reconstructive Surgery, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro)
  • Received : 2022.12.08
  • Accepted : 2023.06.15
  • Published : 2024.05.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background Dupuytren's disease decreases quality of life significantly and often requires surgical treatment, nevertheless there is no actual gold standard. The aim of this study was to introduce the use of minimally invasive pull-through technique. Methods From 2016 to 2020, 52 patients suffering from Dupuytren's contracture were treated with the minimally invasive pull-through technique. We evaluated the improvement in range of motion, pain, disability, and quality of life in the long term. Total extension deficit, quick disabilities of the arm, shoulder, and hand (QuickDASH), and EuroQol five dimensions-five levels index were systematically scored before each surgical intervention and reevaluated after 24 months. Results Fourteen patients (26.9%) had already received a previous intervention (percutaneous needle aponeurotomy or collagenase Clostridium histolyticum). The mean preoperative total active extension deficit was 84.0 ± 23.3 degrees (55-130 degrees). Mean follow-up was 36 months. There were no cases of tendon rupture or neurovascular injury. Total active extension deficit at the final follow-up was 3.4 ± 2.3 degrees (0-12 degrees). The mean active range of motion of the MCP and PIP joints were, respectively, 90.5 ± 3.3 degrees (85-96 degrees) and 82.7 ± 2.5 degrees (80-87 degrees). At 24 months after cord excision, a mean 10.7 points improvement in the QuickDASH questionnaire was registered (p < 0.001). Pull-through technique was equally effective both on patients with a primary or a recurrent disease. Eight patients (15.4%) had a recurrence of disease in the metacarpophalangeal joint or proximal interphalangeal joint. Conclusion The pull-through technique is a simple, accessible, and effective technique for the treatment of Dupuytren's contracture. The use of palmar mini-incisions combined with minimal dissection has a low risk of iatrogenic injury to the neurovascular bundles and tendons, and has a low risk of recurrence rate. This study reflects level of evidence IV.

Keywords

References

  1. Worrell M. Dupuytren's disease. Orthopedics 2012;35(01):52-60  https://doi.org/10.3928/01477447-20111122-23
  2. Desai SS, Hentz VR. The treatment of Dupuytren disease. J Hand Surg Am 2011;36(05):936-942  https://doi.org/10.1016/j.jhsa.2011.03.002
  3. Jain A, Tarabishy S, Carter J, Gonzalez G, Herrera FA. Cost analysis and national trends in the treatment of Dupuytren contracture comparing collagenase injection, needle fasciotomy, and open fasciectomy procedures. Ann Plast Surg 2021;86(6S suppl 5):S625-S627  https://doi.org/10.1097/SAP.0000000000002876
  4. van Rijssen AL, Ter Linden H, Werker PMN. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg 2012;129(02):469-477  https://doi.org/10.1097/PRS.0b013e31823aea95
  5. Zhang D, Earp BE, Benavent KA, Blazar P. Collagenase treatment of Dupuytren's disease with minimum 5-year follow-up: recurrence, reintervention, and satisfaction. Plast Reconstr Surg 2020;146(05):1071-1079  https://doi.org/10.1097/PRS.0000000000007243
  6. Tubiana R. Evaluation of deformities in Dupuytren's disease. Ann Chir Main 1986;5(01):5-11  https://doi.org/10.1016/S0753-9053(86)80043-6
  7. Hueston JT. Table top test. Med J Aust 1976;2(05):189-190  https://doi.org/10.5694/j.1326-5377.1976.tb134472.x
  8. Werker PMN, Pess GM, van Rijssen AL, Denkler K. Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: the importance of clear definitions. J Hand Surg Am 2012;37(10):2095-2105.e7  https://doi.org/10.1016/j.jhsa.2012.06.032
  9. Budd HR, Larson D, Chojnowski A, Shepstone L. The QuickDASH score: a patient-reported outcome measure for Dupuytren's surgery. J Hand Ther 2011;24(01):15-20, quiz 21  https://doi.org/10.1016/j.jht.2010.08.006
  10. Beaton DE, Wright JG, Katz JNUpper Extremity Collaborative Group. Development of the QuickDASH: comparison of three item-reduction approaches. J Bone Joint Surg Am 2005;87(05):1038-1046  https://doi.org/10.2106/JBJS.D.02060
  11. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35(11):1095-1108  https://doi.org/10.1097/00005650-199711000-00002
  12. Felici N, Marcoccio I, Giunta R, et al. Dupuytren contracture recurrence project: reaching consensus on a definition of recurrence. Handchir Mikrochir Plast Chir 2014;46(06):350-354  https://doi.org/10.1055/s-0034-1394420
  13. Kan HJ, Verrijp FW, Hovius SER, van Nieuwenhoven CA, Selles RWDupuytren Delphi Group. Recurrence of Dupuytren's contracture: a consensus-based definition. PLoS ONE 2017;12(05):e0164849 
  14. Hueston JT. Current state of treatment of Dupuytren's disease. Ann Chir Main 1984;3(01):81-92  https://doi.org/10.1016/S0753-9053(84)80066-6
  15. Smith AC. Diagnosis and indications for surgical treatment. Hand Clin 1991;7(04):635-642, discussion 643  https://doi.org/10.1016/S0749-0712(21)00900-8
  16. Paynter JA, Tobin V, Rozen WM, Hunter-Smith DJ. Dupuytren disease management trends: a survey of hand surgeons. J Hand Surg Asian Pac Vol 2020;25(04):453-461  https://doi.org/10.1142/S2424835520500502
  17. Hozack BA, Rayan GM. Surgical treatment for recurrent Dupuytren disease. Hand (N Y) 2023;18(04):641-647  https://doi.org/10.1177/15589447211060447
  18. Kim SW, Hong JP, Lee WJ, Chung YK, Tark KC. Single-stage Achilles tendon reconstruction using a composite sensate free flap of dorsalis pedis and tendon strips of the extensor digitorum longus in a complex wound. Ann Plast Surg 2003;50(06):653-657  https://doi.org/10.1097/01.SAP.0000041479.79049.71
  19. Krefter C, Marks M, Hensler S, Herren DB, Calcagni M. Complications after treating Dupuytren's disease. A systematic literature review. Hand Surg Rehabil 2017;36(05):322-329  https://doi.org/10.1016/j.hansur.2017.07.002
  20. van Rijssen AL, Gerbrandy FSJ, Ter Linden H, Klip H, Werker PMN. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am 2006;31(05):717-725  https://doi.org/10.1016/j.jhsa.2006.02.021
  21. van Rijssen AL, Werker PMN. Treatment of Dupuytren's contracture; an overview of options [in Dutch]. Ned Tijdschr Geneeskd 2009;153:A129 
  22. Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg Br 2003;28(05):427-431  https://doi.org/10.1016/S0266-7681(03)00013-5
  23. Badalamente MA, Hurst LC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg Am 2000;25(04):629-636  https://doi.org/10.1053/jhsu.2000.6918
  24. Peimer CA, Blazar P, Coleman S, Kaplan FTD, Smith T, Lindau T. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-year data. J Hand Surg Am 2015;40(08):1597-1605  https://doi.org/10.1016/j.jhsa.2015.04.036
  25. Cocci A, Russo GI, Salamanca JIM, Ralph D, Palmieri A, Mondaini N. The End of an era: withdrawal of Xiapex (Clostridium histolyticum Collagenase) from the European Market. Eur Urol 2020;77(05):660-661  https://doi.org/10.1016/j.eururo.2019.11.019
  26. Hurst LC, Badalamente MA, Hentz VR, et al; CORD I Study Group. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med 2009;361(10):968-979  https://doi.org/10.1056/NEJMoa0810866
  27. Kasture S, Sakamuri R. Long-term outcomes of collagenase Clostridium histolyticum injection for palmar Dupuytren's deformity correction. Cureus 2021;13(11):e19952 
  28. Zhou C, Hovius SER, Slijper HP, et al. Collagenase Clostridium histolyticum versus limited fasciectomy for Dupuytren's contracture: outcomes from a Multicenter Propensity Score Matched Study. Plast Reconstr Surg 2015;136(01):87-97  https://doi.org/10.1097/PRS.0000000000001320
  29. Gelman S, Schlenker R, Bachoura A, et al. Minimally invasive partial fasciectomy for Dupuytren's contractures. Hand (N Y) 2012;7(04):364-369  https://doi.org/10.1007/s11552-012-9461-x
  30. Basso MA, Bernasconi A, Balato G, Cozzolino A, Famiglietti G, Smeraglia F. Clinical results of collagenase treatment for Dupuytren's disease: a case series study with 2-years follow-up. Acta Ortop Bras 2023;31(spe1):e259218 
  31. Van Beeck A, Van den Broek M, Michielsen M, Didden K, Vuylsteke K, Verstreken F. Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results. Hand Surg Rehabil 2017;36(05):346-349  https://doi.org/10.1016/j.hansur.2017.06.007
  32. Shin EK, Jones NF. Minimally invasive technique for release of Dupuytren's contracture: segmental fasciectomy through multiple transverse incisions. Hand (N Y) 2011;6(03):256-259  https://doi.org/10.1007/s11552-011-9336-6
  33. Moermans JP. Long-term results after segmental aponeurectomy for Dupuytren's disease. J Hand Surg Br 1996;21(06):797-800  https://doi.org/10.1016/S0266-7681(96)80195-1
  34. Moermans JP. Segmental aponeurectomy in Dupuytren's disease. J Hand Surg Br 1991;16(03):243-254 https://doi.org/10.1016/0266-7681(91)90047-R